HLL Lifecare Limited, a Mini-Ratna CPSE under the Ministry of Health and Family Welfare, has showcased robust financial performance by declaring a record dividend of ₹69.53 crore to the Government of India for FY 2024–25 — one of the highest payouts in the company’s history.
The dividend cheque was presented to Shri J.P. Nadda, Hon’ble Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare; Smt. Punya Salila Srivastava, Union Health Secretary; Shri Hovyeda Abbas, AS&FA; and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. Senior officials from HLL, including Shri N. Ajit, Director (Marketing), and Shri Ramesh P, Director (Finance), were also present.
Speaking at the occasion, Shri J.P. Nadda asserted that, HLL is a reliable name in the field of Medical Services and is committed towards the national vision of accessible, affordable and quality healthcare to all.
Commending HLL’s performance, Shri J.P. Nadda, stated that, HLL along with its subsidiaries and Amrit pharmacies have emerged as a key player in transforming the health sector. He highlighted that in the last 10 years, over 6.7 crore people have benefited through the affordable medicines of the Amrit Pharmacies, thereby saving more than Rs. 8000 Crores in terms of their out-of-pocket expenditure.
In FY 2024–25, HLL Lifecare Limited achieved robust growth across its manufacturing and service segments. The company’s revenue from operations rose to ₹4,500 crore, reflecting a 20% year-on-year increase, while its net worth climbed to ₹1,100 crore as of March 31, 2025.
On a consolidated basis, including subsidiaries HITES, GAPL, and Lifespring Hospitals, the HLL Group reported total revenue of ₹4,900 crore — a 19% rise over the previous fiscal year.